ArticleCancer immunology research2022

Tyrosine Kinase Inhibition Alters Intratumoral CD8+ T-cell Subtype Composition and Activity.

Andrew D Tieniber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.